Tech Company Financing Transactions
Gro Biosciences Funding Round
Gro Biosciences closed a $2.1 million Seed financing round on 9/29/2017. Investors included Digitalis Ventures and Innovation Endeavors.
Transaction Overview
Company Name
Announced On
9/29/2017
Transaction Type
Venture Equity
Amount
$2,100,000
Round
Seed
Investors
Digitalis Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds for the buildout of bioprocess development for its platform of genomically recoded bacteria for the production of therapeutic proteins with enhanced properties, such as increased potency and stability, and improved targeting and delivery into cells and tissues.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
127 Western Ave.
Boston, MA 02134
USA
Boston, MA 02134
USA
Phone
Website
Email Address
Not Recorded
Overview
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Mandell
Chief Scientific Officer
Christopher Gregg
Co-Founder
George Church
Co-Founder
Andrew Ellington
Co-Founder
Marc Lajoie
Co-Founder
Ross Thyer
Browse more venture capital transactions:
Prev: 9/29/2017: GroupSolver venture capital transaction
Next: 9/29/2017: LetGo venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs